“Gefitinib: A Pharmacoeconomic Profile of Its Use in Patients With Non Small Cell Lung Cancer EGFR+”. Farmeconomia. Health Economics and Therapeutic Pathways 12, no. 2 (June 1, 2011): 77–85. Accessed December 28, 2025. https://journals.seedstm.com/index.php/FE/article/view/73.